Related Experiment Video
Updated: Nov 23, 2025
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.5K
An Intracellular Model of Hepatitis B Viral Infection: An In Silico Platform for Comparing Therapeutic Strategies
Farzad Fatehi1,2, Richard J Bingham1,2,3, Eric C Dykeman1,2
1York Cross-Disciplinary Centre for Systems Analysis, University of York, York YO10 5GE, UK.
Viruses
|December 30, 2020
Summary
Researchers developed a model of Hepatitis B virus (HBV) infection dynamics. This model helps assess antiviral treatments and found that combining capsid assembly inhibitors is the most effective strategy for HBV cure.
Area of Science:
- Virology
- Computational Biology
- Pharmacology
Background:
- Hepatitis B virus (HBV) infection is a global health concern.
- The World Health Organisation (WHO) aims to eliminate viral hepatitis by 2030.
- Antiviral drug development for HBV is a major research focus.
Purpose of the Study:
- To create a comprehensive model of intracellular HBV infection dynamics.
- To include all molecular processes targeted by current antiviral drugs.
- To assess the impact of different treatment options and their combinations.
Main Methods:
- Development of a mathematical model for HBV infection.
- Inclusion of molecular processes targeted by antiviral drugs.
- Validation of the model against clinical study outcomes.
Main Results:
- The model accurately reflects observed clinical outcomes.
- Unsuspected kinetic behavior in sub-viral particle formation was identified.
- Comparative assessment of treatment options was enabled.
Conclusions:
- The model provides insights into HBV infection dynamics and immune responses.
- Combination therapies, particularly multiple capsid assembly inhibitors, show the best performance.
- This work aids in the development of effective HBV cure strategies.
